Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP351139.RAKSlrHdAjxxuwUu1z_Uukm3aJWKdv0jAqzY4iQtGe1qk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP351139.RAKSlrHdAjxxuwUu1z_Uukm3aJWKdv0jAqzY4iQtGe1qk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP351139.RAKSlrHdAjxxuwUu1z_Uukm3aJWKdv0jAqzY4iQtGe1qk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP351139.RAKSlrHdAjxxuwUu1z_Uukm3aJWKdv0jAqzY4iQtGe1qk130_provenance.
- befree-20150227 importedOn "2015-02-27" NP351139.RAKSlrHdAjxxuwUu1z_Uukm3aJWKdv0jAqzY4iQtGe1qk130_provenance.
- NP351139.RAKSlrHdAjxxuwUu1z_Uukm3aJWKdv0jAqzY4iQtGe1qk130_assertion wasGeneratedBy ECO_0000203 NP351139.RAKSlrHdAjxxuwUu1z_Uukm3aJWKdv0jAqzY4iQtGe1qk130_provenance.
- NP351139.RAKSlrHdAjxxuwUu1z_Uukm3aJWKdv0jAqzY4iQtGe1qk130_assertion wasDerivedFrom befree-20150227 NP351139.RAKSlrHdAjxxuwUu1z_Uukm3aJWKdv0jAqzY4iQtGe1qk130_provenance.
- NP351139.RAKSlrHdAjxxuwUu1z_Uukm3aJWKdv0jAqzY4iQtGe1qk130_assertion SIO_000772 24336067 NP351139.RAKSlrHdAjxxuwUu1z_Uukm3aJWKdv0jAqzY4iQtGe1qk130_provenance.
- NP351139.RAKSlrHdAjxxuwUu1z_Uukm3aJWKdv0jAqzY4iQtGe1qk130_assertion evidence source_evidence_literature NP351139.RAKSlrHdAjxxuwUu1z_Uukm3aJWKdv0jAqzY4iQtGe1qk130_provenance.
- NP351139.RAKSlrHdAjxxuwUu1z_Uukm3aJWKdv0jAqzY4iQtGe1qk130_assertion description "[Of these target genes, the GADD45A promoter region was shown to be hypermethylated in 82% of wild-type TP53 sarcomas that did not respond to Nutlin-3a, thereby providing mechanistic insight into the innate ability of sarcomas to resist apoptotic death following Nutlin-3a treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP351139.RAKSlrHdAjxxuwUu1z_Uukm3aJWKdv0jAqzY4iQtGe1qk130_provenance.